N-[(2S,3S)-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-1-(3,4,5-trimethoxyphenyl)azetidin-3-yl]methanesulfonamide
C20H24N2O8S — CID 131974453
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(2S,3S)-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-1-(3,4,5-trimethoxyphenyl)azetidin-3-yl]methanesulfonamide
N-[(2S,3S)-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-1-(3,4,5-trimethoxyphenyl)azetidin-3-yl]methanesulfonamide (PubChem CID 131974453) has the molecular formula C20H24N2O8S and a molecular weight of 452.49 g/mol. Its IUPAC name is N-[(2S,3S)-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-1-(3,4,5-trimethoxyphenyl)azetidin-3-yl]methanesulfonamide.
Molecular Properties
| Compound Name | N-[(2S,3S)-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-1-(3,4,5-trimethoxyphenyl)azetidin-3-yl]methanesulfonamide |
|---|---|
| PubChem CID | 131974453 |
| Molecular Formula | C20H24N2O8S |
| Molecular Weight | 452.49 g/mol |
| Exact Mass | 452.13 |
| IUPAC Name | N-[(2S,3S)-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-1-(3,4,5-trimethoxyphenyl)azetidin-3-yl]methanesulfonamide |
| SMILES | COc1ccc([C@H]2[C@H](NS(C)(=O)=O)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1O |
| InChI | InChI=1S/C20H24N2O8S/c1-27-14-7-6-11(8-13(14)23)18-17(21-31(5,25)26)20(24)22(18)12-9-15(28-2)19(30-4)16(10-12)29-3/h6-10,17-18,21,23H,1-5H3/t17-,18-/m0/s1 |
| InChIKey | NMDXDVWGNYDIAR-ROUUACIJSA-N |
| XLogP | 1.43 |
| TPSA | 123.63 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 452.49 |
| LogP ≤ 5 | 1.43 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 131974453 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.